The global market for Behçet's disease therapeutics is observing a period of remarkable growth, driven by an increasing prevalence of the disease and advancements in treatment options. The requirement for effective therapies to manage the varying symptoms of Behçet's disease is propelling this development. Pharmaceutical companies are actively re